azacitidine has been researched along with Carcinoma, Embryonal in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araúzo-Bravo, MJ; Do, JT; Han, DW; Jaenisch, R; Lee, HT; Lee, SH; Meissner, A; Schöler, HR | 1 |
Breiling, A; Lyko, F; Musch, T; Oz, Y | 1 |
Baraty, C; Bianco, C; Castro, NP; Gonzales, M; Held, N; Karasawa, H; Rangel, MC; Rollman, K; Salomon, DS; Strizzi, L | 1 |
Armstrong, D; Beyrouthy, MJ; Biswal, BK; Christensen, BC; Hever-Jardine, MP; Marsit, CJ; Spinella, MJ; Tomlinson, CR | 1 |
Schulz, WA; Teubner, B | 1 |
Lee, CH; Wei, LN | 1 |
Eckert, I; Schulz, WA; Stopper, H; Wagener, P | 1 |
7 other study(ies) available for azacitidine and Carcinoma, Embryonal
Article | Year |
---|---|
Epigenetic hierarchy governing Nestin expression.
Topics: Acetylation; Animals; Azacitidine; Carcinoma, Embryonal; Cell Line; Chromatin; Chromatin Immunoprecipitation; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Embryonic Stem Cells; Enhancer Elements, Genetic; Epigenesis, Genetic; Histones; Hydroxamic Acids; Intermediate Filament Proteins; Introns; Mice; Nerve Tissue Proteins; Nestin; Promoter Regions, Genetic; Transcription, Genetic; Tretinoin | 2009 |
Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors.
Topics: Azacitidine; Carcinoma, Embryonal; Caspase 7; Caspase Inhibitors; Cell Differentiation; Cell Line, Tumor; Cytarabine; Decitabine; DNA Damage; DNA Methylation; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Neurons; Octamer Transcription Factor-3; Polycomb-Group Proteins; Protein Processing, Post-Translational; Protein Stability; Repressor Proteins; Stem Cell Factor | 2010 |
Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.
Topics: Azacitidine; Binding Sites; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Embryonal; Cell Movement; Decitabine; DNA Methylation; DNA Modification Methylases; Dose-Response Relationship, Drug; Embryonal Carcinoma Stem Cells; Female; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Genes, Reporter; GPI-Linked Proteins; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Luciferases; MCF-7 Cells; Neoplasm Invasiveness; Neoplasm Proteins; Nuclear Receptor Subfamily 6, Group A, Member 1; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; RNA Interference; RNA, Messenger; Time Factors; Tissue Array Analysis; Transcription, Genetic; Transfection; Tretinoin; Valproic Acid | 2013 |
Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Carcinoma, Embryonal; Cell Line, Tumor; Decitabine; DNA Damage; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Testicular Neoplasms; Tumor Suppressor Protein p53 | 2012 |
Exemption of satellite DNA from demethylation in immortalized differentiated derivatives of F9 mouse embryonal carcinoma cells.
Topics: Animals; Antineoplastic Agents; Azacitidine; Carcinoma, Embryonal; Cell Differentiation; Cell Division; Cell Line; Cell Line, Transformed; Collagen; Decitabine; DNA, Neoplasm; DNA, Satellite; Embryo, Mammalian; Endoderm; Glyceraldehyde-3-Phosphate Dehydrogenases; Kinetics; Methylation; Mice; Pseudogenes; Repetitive Sequences, Nucleic Acid; Restriction Mapping; RNA, Messenger; Stem Cells; Tumor Cells, Cultured | 1994 |
Demethylation in the 5'-flanking region of mouse cellular retinoic acid binding protein-I gene is associated with its high level of expression in mouse embryos and facilitates its induction by retinoic acid in P19 embryonal carcinoma cells.
Topics: Animals; Azacitidine; Base Sequence; Carcinoma, Embryonal; Deoxyribonuclease HpaII; Deoxyribonucleases, Type II Site-Specific; DNA; Embryonic and Fetal Development; Gene Expression Regulation, Developmental; Methylation; Mice; Molecular Sequence Data; Promoter Regions, Genetic; Receptors, Retinoic Acid; Restriction Mapping; RNA, Messenger; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured; Up-Regulation | 1994 |
Formation of micronuclei and inhibition of topoisomerase II in the comet assay in mammalian cells with altered DNA methylation.
Topics: Amsacrine; Animals; Azacitidine; Carcinoma, Embryonal; Cell Differentiation; DNA Methylation; DNA, Neoplasm; Enzyme Inhibitors; Ethyl Methanesulfonate; In Situ Hybridization; Kinetochores; Leukemia L5178; Mammals; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1997 |